In an industry that is always evolving, technology providers must do more than just react. They must respond.
For over 25 years, Glemser has adapted to every charge and change—enhancing our ComplianceAuthor AI®
platform, deepening our expertise, and ensuring consistency, safety, and compliance for our clients.
EMA introduces QRD as a required output for product labeling, supporting standardized regulatory submissions across Europe.
Glemser offers document management solutions for label authors to create label content from approved QRD templates.
EMA establishes standardized requirements for product labeling across the EU to ensure consistency and patient safety.
Glemser supports the harmonization of multilingual labeling by offering structured content solutions, ensuring clear and compliant labels for cross-border distribution.
FDA requires pharmaceutical companies to submit drug labeling in structured XML format for global standardization.
In response, Glemser enhances ComplianceAuthor® legacy solution to generate SPLs on demand, a tool that continues to serve clients today.
EMA introduces stricter safety monitoring requirements, mandating updated safety information and warnings on product labels for real-time risk management.
Glemser’s structured content solutions maintain compliance with evolving safety and transparency requirements.
Industry shifts to cloud-based solutions, enhancing flexibility, scalability, and accessibility for regulatory submissions.
Glemser modernizes its offering by transitioning from on-premise to cloud-based solutions, supporting implementations on AWS and Azure.
The EMA advances the digital transformation of product labeling by promoting structured electronic formats, enabling centralized updates and improving accessibility for patients and healthcare professionals in a multilingual, digital-first environment.
Glemser integrates ePI FHIR and Pharmaledger outputs and provides ePI conversion services to clients.
AI gains momentum, driving advancements in natural language processing (NLP) and large-language models (LLM).
Glemser incorporates NLP and generative AI into ComplianceAuthor AI®, improving its capabilities for streamlined content creation and compliance.
Price controls on the top 100 pharmaceutical products in the market impacts profitability for many companies.
Glemser’s ComplianceAuthor AI® solution helps companies maintain productivity and efficiency, enabling more with fewer resources in response to reduced profitability.
ChatGPT 4.0 is released, advancing AI’s capabilities even futher.
Glemser integrates automated document ingestion and AI author assistance into ComplianceAuthor AI®, prioritizing efficiency and accurate content creation.
